M-Line Pharmacy

M-Line Pharmacy provides customized therapeutic solutions to meet patients' individual needs.

About Us

A Holistic Approach to Pharmacy at M-Line Pharmacy

At M-Line Pharmacy we recognize that each person in the world is unique, their physiology is as singular to them as their fingerprints. Our approach to pharmacy emphasizes the well-being of the whole person; we strongly believe in a multidisciplinary approach to help our patients live their lives to the fullest.

happy family image

Our Branded Products

M-Line Pharmacy is currently the only pharmacy able to compound prescriptions for the Multiprofen CC™ and MultiVisk™ line of prescriptions due to patent and proprietary laws. If you wish to seek an alternative course of treatment, please talk about alternatives with your healthcare practitioner or your doctor. Your decision will not have any effect on the quality of services or care you receive as our patient.


Our Services

Compounded Medications

M-Line's Pharmacy Compounding Division can produce lactose-free, sugar-free, gluten-free, caffeine-free or soy-free compounded medications. Please let us know if you require the removal of an ingredient from any compound we are making for you.

Sterile Compounding

It is the preparation of pharmaceutical compounds in a sterile environment to prevent contamination and maintain patient safety. These products range from injections, inhaled solutions, ophthalmic preparations or irrigation solutions made to suit an individual's specific needs.

Pill Packs

Have you ever sat there wondering if you took your medications that morning? Do you take your medicines at the right time? We can help you and your loved ones track their medications or supplements. Our pharmacists can prepare a blister pack for you or a loved one.

Clinical Trials

Trial Overview Details
Study Title Phase 3 Blinded Randomized Controlled Trial - Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty
Regulatory Approvals Health Canada Clinical Trial Control #: 287614 ClinicalTrials.gov ID: NCT06202989 Click here to read
Primary Outcome Pain Reduction
Secondary Outcomes
  • Reduction in opioid use
  • Patient satisfaction with pain management
  • Incidence of adverse events
Patient Enrollment Ongoing (288 patients; fully powered for primary outcome measure)
Estimated Completion Winter 2025
Trial Overview Details
Study Title Phase 3 Crossover Randomized Controlled Trial - Multiprofen-CC to Reduce Pain in Hand Arthritis
Regulatory Approvals Health Canada Clinical Trial Control #: 297848 ClinicalTrials.gov ID: NCT06202989 Click here to read
Primary Outcome Pain Reduction
Secondary Outcomes
  • Hand function
  • Patient reported improvement
  • Incidence of adverse events
Patient Enrollment Ongoing (88 patients; fully powered for primary outcome measure)
Estimated Completion Spring 2026

Hours of Operation

Day Open Close
Monday to Friday 9:00 am 6:00 pm
Saturday 10:00 am 2:00 pm
Holiday hours Please check our Instagram or Facebook pages for updates.